Founder and CEO of Pherros Biosciences, Nigel Kneafsey, works in the rapidly evolving landscape of the life science industry, surrounded by competitive companies endeavoring tirelessly to innovate and revolutionize the way drugs and medical supplies are developed, manufactured, and delivered. As the driving force behind Pherros Biosciences, he utilizes his expertise in supply chain management and commitment to enhancing access to life-saving medicines to reshape the industry standard approach to production and delivery at Pherros.
At the core of Pherros Biosciences lies its robust supply chain capabilities. Nigel Kneafsey and his team recognize the critical importance of a well-managed supply chain to efficiently and reliably serve the healthcare sector. Pherros proudly supports organizations dedicated to improving access to life-saving medicines, ensuring a seamless flow from synthesis to fulfillment.
Under Nigel Kneafsey’s leadership, Pherros Biosciences continues to empower life science organizations through its comprehensive suite of services. These services encompass the entire drug development lifecycle, including synthesis, analysis, and delivery. Pherros ensures that pharmaceutical companies, research institutions, and healthcare organizations have the resources and support required to efficiently bring their critical innovations to market.
Previously founder and CEO of Options Technology, Nigel Kneafsey established his first company in 1993 with the goal of becoming a globally recognized provider of outsourced IT services to the investment banking industry. Now, three decades on, Kneafsey has proven his ability as a leader and entrepreneur, taking his first company to become a top provider of IT infrastructure to global Capital Markets firms and now taking Pherros Biosciences to similar heights.
Under Kneafsey’s directive, Options provided high-performance managed trading infrastructure and cloud-enabled managed services to over 200 firms globally, including leading global investment banks, hedge funds, and proprietary trading firms. From his position as CEO, Kneafsey focused on maintaining and improving a culture of employee fulfillment and environmental sustainability at Options, which he noted as imperative to long-term success. Employing hundreds of individuals across his career, Kneafsey has developed a concentrated ESG focus surrounding reducing energy usage, improving workplace culture and diversity, and instituting recycling programs in its offices.
Throughout Kneafsey’s tenure as CEO, he successfully mitigated the carbon footprint produced by the data centers operated by Options while simultaneously partnering with a number of green-certified facilities. The firm also consistently provided various employee-focused schemes that encouraged learning and training with certification schemes, in turn providing substantial upward mobility for every worker and rewarding exceptional performance. Armed with a vault of knowledge gained throughout his career, Kneafsey has brought his unique ESG focus to Pherros Biosciences and Genesis Business Humanity Club.
Outside of his position as CEO, Kneafsey utilizes his vast knowledge at the forefront of the industry to guide his organization and offer expertise while also exerting positive changes throughout the wider society. Now incorporated as a proud member of the Genesis Club, Kneafsey has worked with us tirelessly to aid humanitarian efforts in Israel during this difficult period.
Exemplifying the generous disposition of a Genesis Club member, we are proud to be announcing Nigel Kneafsey as an honoree at the RED South Beach, Miami, event on October 26th. During this time, it is critically important for respected business leaders and philanthropists such as Kneafsey to stand up and use their networks to aid in delivering life-changing resources to those who need them most.
